✦ LIBER ✦

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer

✍ Scribed by M Gore; A Oza; G Rustin; J Malfetano; H Calvert; D Clarke-Pearson; J Carmichael; G Ross; R.A Beckman; S.Z Fields

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II clinical trial of topotecan a

✍ F. VECCHIONE; R. FRUSCIO; T. DELL’ANNA; A. GARBI; R. GARCIA PARRA; S. CORSO; A.A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

789 A meta-analysis of efficacy data fro

✍ J. Eckardt; J. von Pawel; Z. Papai; P. Wissel; G.A. Ross 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Patient preference and pharmacokinetics

✍ M.M Borner; P Schöffski; R de Wit; F Caponigro; G Comella; A Sulkes; G Greim; G. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Cost-minimisation analysis of pegylated

✍ Ojeda, B; de Sande, L M; Casado, A; Merino, P; Casado, M A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Paclitaxel/carboplatin versus topotecan/

✍ Giorgio Bolis; Giovanna Scarfone; Francesco Raspagliesi; Giorgia Mangili; Saveri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Topotecan versus treosulfan, an alkylati

✍ Werner Meier; Andreas du Bois; Alexander Reuss; Walther Kuhn; Sigrid Olbricht; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 545 KB